Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Walmar Clinical ApS
APS
Active
Advertising protection
CVR 43237381
Stolbjergvej 26C, 3070
Snekkersten
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2022 · 4 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Walmar Clinical ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
1M
2M
2M
1M
2022
2M
2023
2M
2024
EBITDA
DKK millions
1M
1M
1M
0M
0M
1M
2022
1M
0%
2023
1M
0%
2024
Income statement
DKK thousands
Item
2022
2023
2024
Gross profit
1.125
1.910
1.946
Staff expenses
-391
-1.135
-1.146
EBITDA
733
775
800
Depreciation & amort.
-0
-0
-0
EBIT
733
775
800
Net financials
49
156
-1
Profit before tax
782
931
800
Tax
172
206
176
Net profit
610
725
623
Balance sheet
DKK thousands
Item
2022
2023
2024
Total assets
969
2.121
2.419
Equity
650
775
666
Long-term debt
0
0
0
Short-term debt
319
1.346
1.753
Total debt
319
1.346
1.753
Financial ratios
5-year trend
EBITDA margin (of gross profit)
41.1%
This company
2022
2024
Equity ratio
27.5%
This company
38.2%
Market median
-28% vs market
2022
2024
Return on equity
93.6%
This company
18.4%
Market median
+409% vs market
2022
2024
Net profit margin (of gross profit)
32.0%
This company
2022
2024
Asset turnover (of gross profit)
0.80×
This company
2022
2024
Debt / equity
2.63×
This company
0.62×
Market median
-324% vs market
2022
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-05-03 – 2022-12-31
View
PDF
More on Walmar Clinical ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
